Edgewell Personal Care Announces Sale of Feminine Care Business to Essity for $340M

Core Viewpoint - Edgewell Personal Care Company has entered into a definitive agreement to sell its feminine care business to Essity for $340 million, aiming to streamline its portfolio and focus on core competitive areas [1][2][3]. Transaction Details - The transaction is expected to close in the first quarter of calendar 2026, pending regulatory approvals [2]. - Edgewell's feminine care brands include Playtex®, Stayfree®, Carefree®, and o.b.® [2]. - Proceeds from the sale will primarily be used to strengthen Edgewell's balance sheet and invest in long-term growth of its core businesses [2]. Strategic Implications - The sale is seen as a pivotal step in Edgewell's transformation, allowing the company to sharpen its focus on core categories and enhance its financial position for sustainable growth [3]. - The acquisition will enable Essity to strengthen its personal care business in North America, aligning with its strategy to focus on high-yield categories [3]. Transition Support - Edgewell will collaborate with Essity to ensure a smooth transition for employees, customers, and consumers, providing certain services to support the transition post-transaction [4]. Financial Impact - Beginning in the first quarter of fiscal 2026, Edgewell will classify the feminine care business as discontinued operations [5]. - The sale is expected to impact adjusted EPS by approximately $0.40 to $0.50 and adjusted EBITDA by $35 to $45 million, net of income from transition support services [5].